A Comparison in the Use of the Crystallographic Structure of the Human A1 or the A2A Adenosine Receptors as a Template for the Construction of a Homology Model of the A3 Subtype

被引:6
作者
Margiotta, Enrico [1 ]
Moro, Stefano [1 ]
机构
[1] Univ Padua, MMS, Dipartimento Sci Farmaco, Via Marzolo 5, I-35131 Padua, Italy
来源
APPLIED SCIENCES-BASEL | 2019年 / 9卷 / 05期
关键词
G protein-coupled receptor; adenosine receptors; A(3) adenosine receptor; homology modeling; molecular docking; structure-activity relationship; SUPERVISED MOLECULAR-DYNAMICS; LIGAND RECOGNITION; SUMD; IDENTIFICATION; DERIVATIVES; SELECTIVITY; EXPLORE; CLONING; DESIGN; SERIES;
D O I
10.3390/app9050821
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the last decades, the field of therapeutic application in targeting the human A(3) adenosine receptor has represented a rapidly growing area of research in adenosine field. Both agonists and antagonists have been described to have a potential application in the treatment of several diseases, including, for example, glaucoma, cancer, and autoimmune inflammations. To date, the most severe factor limiting the accuracy of the structure-based molecular modeling approaches is the fact that the three-dimensional human A(3) structure has not yet been solved. However, the crystallographic structures of either human A(1) or A(2A) subtypes are available as potential templates for the construction of its homology model. In this study, we have compared the propensity of both models to accommodate a series of known potent and selective human A(3) agonists and antagonists. As described, on the basis of the results obtained from this preliminary study, it is possible to affirm that the human A(3) receptor model based on the crystallographic structure of the A(1) subtype can represent a valid alternative to the one conventionally used today, based on the available A(2A) structures.
引用
收藏
页数:19
相关论文
共 55 条
  • [1] Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor
    Auchampach, John A.
    Gizewski, Elizabeth T.
    Wan, Tina C.
    de Castro, Sonia
    Brown, Garth G., Jr.
    Jacobson, Kenneth A.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2010, 79 (07) : 967 - 973
  • [2] Bairoch A, 1997, J MOL MED-JMM, V75, P312
  • [3] Belardinelli L., 1995, ADENOSINE ADENINE NU
  • [4] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [5] PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART
    Borea, Pier Andrea
    Gessi, Stefania
    Merighi, Stefania
    Vincenzi, Fabrizio
    Varani, Katia
    [J]. PHYSIOLOGICAL REVIEWS, 2018, 98 (03) : 1591 - 1625
  • [6] Adenosine receptors and asthma
    Brown, R. A.
    Spina, D.
    Page, C. P.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 : S446 - S456
  • [7] Rare coding variants of the adenosine A3 receptor are increased in autism: on the trail of the serotonin transporter regulome
    Campbell, Nicholas G.
    Zhu, Chong-Bin
    Lindler, Kathryn M.
    Yaspan, Brian L.
    Kistner-Griffin, Emily
    Hewlett, William A.
    Tate, Christopher G.
    Blakely, Randy D.
    Sutcliffe, James S.
    [J]. MOLECULAR AUTISM, 2013, 4
  • [8] Structural Probing and Molecular Modeling of the A3 Adenosine Receptor: A Focus on Agonist Binding
    Ciancetta, Antonella
    Jacobson, Kenneth A.
    [J]. MOLECULES, 2017, 22 (03)
  • [9] Advances in Computational Techniques to Study GPCR-Ligand Recognition
    Ciancetta, Antonella
    Sabbadin, Davide
    Federico, Stephanie
    Spalluto, Giampiero
    Moro, Stefano
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (12) : 878 - 890
  • [10] Alternative Quality Assessment Strategy to Compare Performances of GPCR-Ligand Docking Protocols: The Human Adenosine A2A Receptor as a Case Study
    Ciancetta, Antonella
    Cuzzolin, Alberto
    Moro, Stefano
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (08) : 2243 - 2254